New Study Links Ozempic to Increased Risk of Suicidal Thoughts

Researchers call for further investigation into the safety of the popular diabetes and weight loss drug.

Study finds a higher incidence of suicidal ideation in patients using semaglutide, especially those with mental health conditions.
Researchers analyzed data from over 28 million adverse drug reaction reports in a WHO database.
The study highlights the need for cautious prescribing, particularly for patients with anxiety and depression.
Experts urge more extensive research to understand the potential risks and mechanisms involved.
Regulatory agencies in the US and Europe are reviewing safety data on GLP-1 receptor agonists.